Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-23,646
Closed -$387K 2474
2025
Q4
$387K Sell
23,646
-36,120
-60% -$636K ﹤0.01% 1766
2025
Q3
$1.12M Sell
59,766
-4,272
-7% -$76.6K 0.01% 1029
2025
Q2
$1.29M Buy
64,038
+24,362
+61% +$421K 0.01% 863
2025
Q1
$592K Buy
39,676
+22,550
+132% +$310K 0.01% 1060
2024
Q4
$196K Buy
+17,126
New +$270K ﹤0.01% 1539

Other funds holding XP

&Partners's XP Position: Q1 2026 in Review

&Partners sold out of XP (XP) in Q1 2026, closing a stake of 23,646 shares — an estimated $387K sold.

&Partners first reported a position in XP in Q4 2024 and held it in 5 quarters. The position peaked at $1.29M in Q2 2025. 356 funds tracked by Wall St. Rank hold XP as of Q1 2026.

  • &Partners reported no remaining XP position as of Q1 2026 after selling out during the quarter.
  • &Partners sold 23,646 XP shares in Q1 2026, an estimated $387K.
  • &Partners first reported a position in XP in Q4 2024 and held it in 5 quarters.
  • &Partners's XP position peaked at $1.29M in Q2 2025.
  • 356 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.